Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
- PMID: 34093561
- PMCID: PMC8170319
- DOI: 10.3389/fimmu.2021.667179
Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
Abstract
Objective: Tryptophan catabolites (TRYCATs) are implicated in the pathophysiology of mood disorders by mediating immune-inflammation and neurodegenerative processes. We performed a meta-analysis of TRYCAT levels in bipolar disorder (BD) patients compared to healthy controls.
Methods: A systematic literature search in seven electronic databases (PubMed, Embase, Web of Science, Cochrane, Emcare, PsycINFO, Academic Search Premier) was conducted on TRYCAT levels in cerebrospinal fluid or peripheral blood according to the PRISMA statement. A minimum of three studies per TRYCAT was required for inclusion. Standardized mean differences (SMD) were computed using random effect models. Subgroup analyses were performed for BD patients in a different mood state (depressed, manic). The methodological quality of the studies was rated using the modified Newcastle-Ottawa Quality assessment Scale.
Results: Twenty-one eligible studies were identified. Peripheral levels of tryptophan (SMD = -0.44; p < 0.001), kynurenine (SMD = - 0.3; p = 0.001) and kynurenic acid (SMD = -.45; p = < 0.001) were lower in BD patients versus healthy controls. In the only three eligible studies investigating TRP in cerebrospinal fluid, tryptophan was not significantly different between BD and healthy controls. The methodological quality of the studies was moderate. Subgroup analyses revealed no significant difference in TRP and KYN values between manic and depressed BD patients, but these results were based on a limited number of studies.
Conclusion: The TRYCAT pathway appears to be downregulated in BD patients. There is a need for more and high-quality studies of peripheral and central TRYCAT levels, preferably using longitudinal designs.
Keywords: bipolar disorder; depression; immune; inflammation; kynurenine; tryptophan.
Copyright © 2021 Hebbrecht, Skorobogatov, Giltay, Coppens, De Picker and Morrens.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.PLoS One. 2017 Feb 27;12(2):e0172699. doi: 10.1371/journal.pone.0172699. eCollection 2017. PLoS One. 2017. PMID: 28241062 Free PMC article.
-
A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.Bipolar Disord. 2020 Feb;22(1):59-69. doi: 10.1111/bdi.12814. Epub 2019 Aug 30. Bipolar Disord. 2020. PMID: 31398273
-
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis.BMC Infect Dis. 2022 Jul 15;22(1):615. doi: 10.1186/s12879-022-07582-1. BMC Infect Dis. 2022. PMID: 35840908 Free PMC article.
-
The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites.Mol Psychiatry. 2021 Jul;26(7):3419-3429. doi: 10.1038/s41380-020-00913-1. Epub 2020 Oct 19. Mol Psychiatry. 2021. PMID: 33077852
-
The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.J Alzheimers Dis. 2022;88(4):1325-1339. doi: 10.3233/JAD-220295. J Alzheimers Dis. 2022. PMID: 35786655
Cited by
-
Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood.Front Pharmacol. 2022 Feb 15;13:825948. doi: 10.3389/fphar.2022.825948. eCollection 2022. Front Pharmacol. 2022. PMID: 35250576 Free PMC article. No abstract available.
-
Sex Differences in Tryptophan Metabolism: A Systematic Review Focused on Neuropsychiatric Disorders.Int J Mol Sci. 2023 Mar 22;24(6):6010. doi: 10.3390/ijms24066010. Int J Mol Sci. 2023. PMID: 36983084 Free PMC article.
-
The Microbiota-Gut-Brain Axis in Psychiatric Disorders.Int J Mol Sci. 2022 Sep 24;23(19):11245. doi: 10.3390/ijms231911245. Int J Mol Sci. 2022. PMID: 36232548 Free PMC article. Review.
-
The future of immunopsychiatry: Three milestones to clinical innovation.Brain Behav Immun Health. 2021 Jul 30;16:100314. doi: 10.1016/j.bbih.2021.100314. eCollection 2021 Oct. Brain Behav Immun Health. 2021. PMID: 34589805 Free PMC article.
-
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders.Front Immunol. 2021 Sep 23;12:716980. doi: 10.3389/fimmu.2021.716980. eCollection 2021. Front Immunol. 2021. PMID: 34630391 Free PMC article.